Cancerify Logo

Dr. Michael J. Morris

Medical Oncologist, specializing in prostate cancer

Cancer Treated:

353 East 68th Street New York NY 10065
646-422-4469

Dr. Michael J. Morris, MD, is a nationally recognized medical oncologist specializing in advanced prostate cancer. He serves as Section Head of Prostate Cancer in the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center, where he also holds the Steven A. Greenberg Chair in Prostate Cancer Research. Dr. Morris earned his medical degree from the Icahn School of Medicine at Mount Sinai and completed his internal medicine residency at Columbia-Presbyterian Medical Center. He subsequently pursued a fellowship in medical oncology at Memorial Sloan Kettering, where he has since built a distinguished career in prostate cancer therapeutics and imaging.

Dr. Morris is known for his leadership in developing targeted radiopharmaceutical therapies and molecular imaging for metastatic castration-resistant prostate cancer. He played a key role in the development and clinical integration of ^177Lu-PSMA-617, a radioligand therapy approved for patients with advanced disease. His research focuses on the use of prostate-specific membrane antigen (PSMA) PET imaging to refine treatment selection and monitor disease progression. He has authored numerous peer-reviewed publications and serves in national leadership roles, including chairing the Prostate Cancer Clinical Trials Consortium and contributing to the NCI Alliance for Clinical Trials in Oncology.

Beyond his research and clinical leadership, Dr. Morris is a dedicated mentor and educator, guiding trainees and junior investigators in prostate cancer research, clinical trial design, and biomarker-driven therapies. Board-certified in medical oncology, he is widely respected for his patient-focused, multidisciplinary approach and his contributions to expanding therapeutic options in prostate cancer. Through his continued work in imaging innovation, radiopharmaceutical therapy, and academic leadership, Dr. Morris remains a driving force in advancing care for men with advanced prostate cancer.

Book An Appointment